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Summary 
Coxiella burnetii, the agent of Q fever, is recognised as a worldwide zoonosis with a wide 
host range and potentially complex reservoir systems. Infected ruminants are the main 
source of infection for humans, but cats and other mammals, including wild rodents, 
also represent potential sources of infection. There has been a recent upsurge of 
reported cases in humans, domestic ruminants and wildlife in many parts of the world, 
and studies have indicated that wild brown rats may act as true reservoirs for C. 
burnetii and be implicated in outbreaks in livestock and humans. However, investigation 
of reservoir systems is limited by lack of validated serological tests for wildlife or other 
non-target species. In this study, serum samples from 796 wild rodents (180 bank voles, 
309 field voles, 307 wood mice) 102 wild foxes and 26 domestic cats from three study 
areas in the UK were tested for the presence of antibodies to C. burnetii using a 
commercial indirect ELISA kit modified for use in multiple wildlife species. Test 
thresholds were determined for each species in the absence of species-specific reference 
sera using a bi-modal latent class mixture model to discriminate between positive from 
negative results. Based on the thresholds determined, seroprevalence in the wild rodents 
ranged from 15.6% to 19.1% depending on species (overall 17.3%), and was 
significantly higher in both foxes (41.2%) and cats (61.5%) than in rodents. This is the 
first report to quantify seroprevalence to C. burnetii in bank voles, field voles, wood 
mice, foxes and cats in the UK, and provides evidence that predator species could act as 
indicators for the presence of C. burnetii in rodents. The study demonstrates that 
wildlife species could be significant reservoirs of infection for both livestock and 
humans, and the high seroprevalence in domestic cats highlights the potential zoonotic 
risk from this species. 
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Introduction 
Coxiella burnetii is an obligate intracellular proteobacterium belonging to the family 
Rickettsiaceae and is the aetiological agent of Q fever, a worldwide zoonotic pathogen 
(Woldehiwet 2004). There has been a recent upsurge of reported cases in humans, domestic 
ruminants and wildlife in many parts of the world, in particular in the Netherlands, and also 
in the UK (Amitai et al. 2010; Enserink 2010; Koch et al. 2010; Lemos et al. 2010; Ruiz-
Fons et al. 2008;van der Hoek W. et al. 2010;Wallensten et al. 2010). 
C. burnetii has a very wide host range and has been found in many host species, including 
vertebrate and invertebrate taxa (Babudieri 1959), and is unique among the family 
Rickettsiaceae in its non-dependence on arthropod transmission. Although it can be found in 
ticks and other arthropods, the main source of infection for domestic animals and humans is 
exposure to parturient secretions by inhalation of contaminated aerosols (Angelakis and 
Raoult 2010;Woldehiwet 2004). The major mode of infection is via aerosol (inhalation), but 
infection by ingestion of contaminated dairy products is also possible (Woldehiwet 2004), 
and ingestion of infected prey species has been implicated as a means of infection in cats 
(Komiya et al. 2003). The organism is found in the blood, lungs, spleen and liver, and is shed 
in urine and faeces. During pregnancy, in both humans and other animals, there is massive 
contamination of the placenta with C. burnetii which can lead to abortion or low foetal birth 
weight (Babudieri 1959;Carcopino et al. 2009). The mammary glands are also infected and 
large numbers of bacteria can be found in milk. The extracellular form of C. burnetii is 
resistant to killing by desiccation, low or high pH, or by disinfectants such as 0.5% sodium 
hypochlorite or UV radiation. Therefore it can be persistent in the environment for several 
weeks, and can also be spread by the wind, so direct contact with animals is not necessary for 
infection to occur (Maurin and Raoult 1999).  
 4 
Domestic ruminants (cows, sheep, and goats) are the main source of infection for humans, 
but the wide range of host species comprising arthropods, birds and mammals, including 
small rodents (Burgdorfer 1963;Woldehiwet 2004), dogs and horses (Roest 2013), suggests 
that complex reservoir systems may exist. C. burnetii has been isolated from hares (Marrie et 
al. 1993), wild mice and rabbits, and Q fever pneumonia in humans has been linked to 
exposure to wild rabbits (Marrie et al. 1986). In man, exposure to wildlife has been identified 
as a risk factor for seropositivity to Q fever in a recent survey of US veterinarians (Whitney 
et al. 2009). In the UK, antibodies to C. burnetii have been detected in wild brown rats on 
farms (Webster et al. 1995). Recent studies in the Netherlands have also indicated that wild 
brown rats, especially those near farms, may act as true reservoirs for C. burnetii (Reusken 
2011) and may be implicated in the recent outbreaks in livestock and humans in the 
Netherlands.  
Cats are also now recognised as an important host species and have been implicated in 
human outbreaks of Q fever (Kosatsky 1984). C. burnetii DNA is found in vaginal and 
uterine samples from healthy cats (Cairns et al. 2007), and thus parturient cats are a zoonotic 
risk (Woldehiwet 2004). A Japanese study found a higher seroprevalence to C. burnetii in 
stray cats (41.7%) compared with pet cats (14.2%) (Komiya, Sadamasu, Kang, Tsuboshima, 
Fukushi, & Hirai 2003), with a greater consumption of wild prey (rodents, birds) suggested 
as an explanation for the higher seroprevalence in the stray animals. However, in a search for 
additional reservoirs for human Q fever in the outbreak affecting the Netherlands for 2007-
2010, no C. burnetii DNA was isolated from the placentas of domestic cats and the study 
provided no indication for major reservoirs of C. burnetii in cats, goats or pigs in this 
outbreak (Roest 2013). In the same study, C. burnetii DNA was detected in both dogs and 
horses (Roest 2013). Dogs are a known domestic animal reservoir (Woldehiwet 2004) of C. 
burnetii and human infection has been directly linked to pet dogs (Komiya et al., 2003b). 
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Evidence of infection has also been found in wild canids, such as grey fox and coyote 
(Enright et al. 1971). 
Being an intracellular pathogen, serological testing is mainly relied upon for detection (OIE 
2008). However, commercially available ELISA kit tests for serological testing of C. burnetii 
are designed for use in domestic ruminants and are not validated for wildlife species. 
Common difficulties encountered with serological testing of wildlife species using indirect 
ELISA methodologies are the lack of species-specific secondary antibodies and the lack of 
species-specific reference sera (positive and negative controls) which both hamper the 
validation and assessment of performance of the assay used. Therefore there is a need to 
develop and validate ELISA testing methodologies to enable their use on multiple species 
including wildlife. Use of an identical test on multiple species is likely to be more cost-
efficient and effective use of resources when undertaking serological studies for C. burnetii 
than using a specific test for each individual species. 
The aim of this study was to investigate the seroprevalence of C. burnetii in three species of 
wild rodents (bank voles (Myodes glareolus), field voles (Microtus agrestis) and wood mice 
Apodemus sylvaticus)), red foxes (Vulpes vulpes) and domestic cats in the UK using a 
modified indirect ELISA kit adapted for use in multiple species. 
Materials and methods 
Sample collection 
Serum samples were collected from wild rodents, foxes and domestic cats in three rural study 
sites of varying habitat in northern England (Cumbria) and Scotland (Pentlands and Borders) 
over a twenty-nine month period (April 2007- October 2009) (For details of sampling dates 
see Figure 1 (Meredith 2013). 
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Wild rodents were trapped and blood sampled as described in Meredith et al (2013). Rodent 
trapping was carried out over four seasons (April-August 2007; November 2007 - March 
2008; April - August 2008; November 2008-December 2008).  
Foxes were shot as part of routine pest control operations and blood collected from the 
thoracic or abdominal cavity within 24 hours of death. Cat blood samples were obtained via 
veterinary surgeons from animals presented for veterinary examination where a blood sample 
was routinely taken, and surplus serum was submitted for the study. An owner questionnaire 
was used to confirm that the cats submitted for the study were known to hunt and consume 
wild rodents. The sampling methodology was approved by the University of Edinburgh’s 
Ethical Review Committee. 
For all samples, serum was separated by centrifugation at 4000rpm within 24 hours of 
collection and stored at -70C. Foxes and cat samples were collected opportunistically 
throughout the study period. Location (grid reference), age class (adult/ non-adult), and sex 
were recorded for all animals. 
Modified indirect ELISA 
Serum was tested using a modified commercial indirect ELISA kit adapted for the purposes 
of this study by the manufacturer for use in multiple non-ruminant species (IDVet, 
Montpellier, France). This was achieved by replacing the species- specific (ruminant) 
conjugate with a mixture of protein A and G peroxidase conjugate to detect bound serum 
(LeCoq, IDVet, personal communication). 96-microwell plates were supplied pre-coated 
with phase I and phase II antigens, from a C. burnetii strain isolated in France from an 
aborted bovine placenta. All reagents and solutions were supplied directly by the 
manufacturer. Briefly, 90 µl of dilution buffer was added to each microwell and 10 µl of each 
test serum and a positive and negative control serum added in duplicate to the wells and 
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incubated for 45 minutes at room temperature. Wells were washed with approximately 300 
µl wash solution three times. 100 µl conjugate (protein A and G) was added to each well, and 
the plate incubated for 30 minutes at room temperature. Wells were washed with 
approximately 300 µl Wash Solution three times 100 µl substrate solution was added to each 
well and the plate incubated for 15 minutes at room temperature in the dark. The reaction 
was stopped by adding 100 µl stop solution (H2SO4) to each well and the optical densities 
measured on a Model 550 microplate reader (Bio-Rad Laboratories, Hemel Hempstead, UK) 
reader at 450nm. The test results were deemed valid as per manufacturer’s instructions if the 
mean optical density (OD) of the 2 positive controls (ODPC) was > 0.350 and the ratio of the 
mean OD values of the 2 positive and 2 negative controls was > 3. The sample:positive 
control (S/P) percentage was calculated using the formula 
 S/P = OD sample - ODnc  x 100 
 ODpc - ODnc 
 
Threshold determination 
The modified ELISA developed for this study could not be validated prior to deployment, as 
known confirmed seronegative and seropositive samples for the wildlife species tested and 
cats were not available and the commercial ELISA on which this was based has only been 
validated for livestock, which may have substantially different immune responses to C. 
burnetii compared to the target species. In the absence of any validation against a gold 
standard, we used a statistical method of ELISA threshold selection in these species as 
outlined in Opsteegh et al. 2010. Briefly, a bi-modal normal distribution was fitted to the 
observed ELISA values to obtain estimates for the mean and standard deviation of the two 
distributions representing negative and positive results. This model was fitted using Bayesian 
Markov chain Monte Carlo methods (Gilks 1998), implemented using the JAGS software 
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(Plummer 2013) interfaced using the ‘runjags’ package (Denwood 2013) from R (R Core 
Team 2013). Nine chains with over-dispersed starting values were used, and trace plots 
visually assessed to ensure convergence. The posterior distributions were output from this 
simulation and subsequently used to calculate the optimum threshold value (defined as the 
highest total sensitivity and specificity of the test) for each iteration of parameter values, 
using two cumulative distribution functions to calculate the probability of observing an 
ELISA value above and below the given threshold for the negative and positive groups 
respectively. Uncertainty regarding the true parameter values representing negative and 
positive groups was reflected in a full posterior distribution for optimised threshold, with the 
mean of this distribution taken as the best estimate for the new test threshold. The data was 
split into prey (the 3 rodent species) and predator (cat and fox) data to reflect possible 
differences in the threshold, and the process above repeated on each dataset. 
Data analysis 
Generalised linear mixed-effect models with binomial errors (GLMEb) were used to consider 
the variation in seroprevalence (based on the calculated thresholds as described above) 
between host species and within host species. For the main analyses the study area the 
samples came from was entered as a random effect to take account of area related infection 
pressures. In addition, individual study sites within areas were entered as a random effect 
nested within study area for rodent species. Sex and age of host species and sampling season 
were incorporated as fixed effects in different univariate models. For age, animals were 
classed as either adult or non-adult (juvenile and subadult). In addition, differences between 
the seroprevalences of the 3 rodent species within each study site were also considered in 
separate GLMEb with just study site as the random effect. All these analyses were carried out 
in R (R Core Team 2013). The spatial clustering of seropositive and negative animals in each 
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study area in both rodents and predator species was investigated using Bernouilli statistical 
spatial models of the number of positive animals at a particular location (Kulldorff 1997) in 
SaTScan (v9.1.1 www.satscan.org). Statistical significance level was placed at P<0.05. 
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Results 
A total of 924 serum samples were tested for antibodies to C. burnetii, from 793 rodent 
species (180 bank voles (BV), 309 field voles (FV), 307 wood mice (WM)), 26 cats and 102 
foxes (Table 1). The majority of samples for both rodents and foxes were collected in 
seasons 1 to 3, and in season 4 only the Cumbria study area was sampled for rodent species. 
Most of the cat samples were obtained after season 3, with cat samples from the Borders and 
Pentlands study areas collected up to over a year after the last rodent sampling in those areas. 
Fox samples were collected throughout the study. All 3 rodent species were found in the 3 
study areas. 
Threshold determination 
The MCMC mixed model converged upon two distinct distributions for both the predator and 
prey species, with median estimates of 6.9 (95% credible intervals: 6.8-7.0) and 22.7 (20.8-
22.7) representing the mean of the negative and positive prey distributions, and median 
estimates of 11.4 (10.4-12.8) and 24.5 (21.0-28.3) representing the mean of the negative and 
positive predator distributions. These fitted distributions are shown along with the observed 
data in Figure 1. While it did not make any qualitative difference to the final results, the S/P 
of 98.1 in the predator data and 58.9 in the prey data were excluded from the threshold 
determination procedure as this improved convergence and reduced the spread of the 
posteriors, for the loss of 0.78% and 0.13% of the values. Based on the posterior estimates 
for the distributional parameters obtained, the threshold optimisation procedure described 
produced best estimates for the prey and predator thresholds of 10.27 and 16.31, respectively. 
Based on these thresholds and distributions fitted to the observed data, our modified ELISA 
test has a median sensitivity of 93.5% (95% credible interval 88.4-97.6%) and specificity of 
99.2% (98.8-99.6) for prey, and a median sensitivity of 89.0% (76.6-100) and specificity of 
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97.9% (86.7-100) for predators.  
Rodent species 
The overall seroprevalence in the three rodent species was 17.3% (Table 1). Within 
individual rodent species, there was no significant difference in seroprevalence (15.6-19.1%, 
P>0.403). In addition, there was no significant difference in seroprevalence in bank voles 
(13.1-19.6%), field voles (6.1-28.9%), or wood mice (1.8-19.0%) between study sites 
(P>0.137), though only 17 bank voles were obtained from the Pentlands site. Furthermore, no 
significant difference in seroprevalence was found between rodent species within any of the 
study areas (P>0.301, Table 1).  
There was a significantly greater seroprevalence in female rodents (90/383; 23.6%) 
compared to male rodents (48/404; 11.9%, P=0.005). The greater prevalence in females was 
observed in all 3 rodent species, significantly so for wood mice (F=22.8%, M=10.9%, 
P=0.002; bank voles F=23.3%, M=13.3%, P=0.254; field voles F=24.2%, M=12.1%, 
P=0.350). Only 1/21 non-adult rodent (wood mouse) was seropositive (4.7%), compared to 
137/795 (17.9%) adults..  
Seasonality and spatial patterns 
There was a significance difference in seroprevalence between seasons (P<0.001), with an 
increase in seroprevalence from an average of <3% at the start of the study (Season 1) to 
~50% at the end (P<0.001, Figure 2). This increase was observed in all 3 rodent species 
separately (P<0.001, Supp Figure 1) with no difference in the rate of increase between prey 
species (P>0.051). However, this pattern was not observed in all 3 study areas – with no 
increase observed in the Borders study area overall (P=0.959) or individual prey species 
(P>0.305). In contrast, an increase was observed both in the Cumbrian and Pentlands study 
areas overall (P<0.001, Supp Figure 1) and in individual prey species (Cumbria P<0.0498, 
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Pentlands P<0.010).  
All rodent trapping locations in the Pentlands site included at least one seropositive rodent 
(seroprevalence range 6.4-60% Figure 3), as did all Cumbrian locations with >7 rodents 
trapped (11/15 locations, range 4.8-38%). In contrast, only 3/7 of Border rodent trapping 
locations had rodents with a seroprevalence >0% and levels were in general lower (range 3.6-
21%). This variation in seroprevalence with trapping location was reflected in 2 statistically 
significant spatial clusters in the Borders study area (P<0.001), one associated with the 2 
most easterly rodent trapping locations with the greatest seroprevalence (>16%) and the other 
with the 4 negative trapping locations. In addition, 3 clusters were identified in the Pentlands 
study area (P<0.001) with the 2 trapping locations with seroprevalences >57% considered as 
separate spatial clusters of high seroprevalence and the 2 most southerly trapping locations a 
cluster of low seroprevalence. No such spatial clusters for low or high seroprevalence were 
detected in the Cumbrian study site rodent data (P>0.369, Figure 3).  
Predators 
The overall seroprevalence in predators was 45.3% (Table 1), and while the seroprevalence 
in cats (61.5%) was greater than that of the foxes (41.2%) this was not significant (P=0.066). 
There was also no significant difference in seroprevalence in cats between the study areas 
(18.2-72.7%, P>0.278), though only <12 samples from cats were obtained from any single 
study area. In contrast, the seroprevalence in samples obtained from foxes in the Borders area 
(64.1%) was significantly higher than those obtained from Cumbria (26.1%, P=0.002) and 
higher than samples obtained from the Pentlands study area (29.4%, P=0.052). There was 
also a significantly higher seroprevalence in samples from cats in Cumbria (66.7%) 
compared to the foxes (26.1%, P=0.027). No such significant difference was observed 
between the predator species in the Borders (72.7 vs. 64.1%, P=0.595) and Pentlands (33.3 
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vs. 29.4%, P=0.858).  
Seroprevalence was not significantly different between sexes (F=22/41=53.7%, 
M=33/62=53.2%, P=0.893), nor was any differences within cats (F=75.0%, M=62.5%, 
P=0.676) or foxes (F=48.5%, M=50.0%, P=0.946). Only adult cats were sampled, and no 
difference in seroprevalence was observed between adult (25/46, 44.6%) and non-adult foxes 
(14/24, 58.3%, P=0.768). 
Seasonality and spatial patterns 
While there was no overall seasonal pattern in seroprevalence of the predator species 
combined (P=0.460) or if foxes were considered alone (P=0.083), there was a change in 
seroprevalence in cats with time (P=0.032), from 96.8% in the autumn of 2008 down to 
28.3% by spring 2009. There was no statistical evidence of spatial clustering of infection, 
either when predators were considered overall, or if just foxes were considered within each 
study area (P>0.133, Figure 3).  
 
Predator and rodent comparison 
Seroprevalence was statistically significantly higher in predators compared to rodents for the 
study overall (P<0.001, Table 1, Figure 3). Furthermore the seroprevalence in both foxes 
and cats were statistically significantly higher than all individual rodent species (P<0.001). 
However, there was no statistically significant correlation between the overall levels of 
seroprevalence observed in the different rodent sample seasons in prey and predator species 
in the 3 study areas (P=0.072). In addition, if individual prey species were considered or if 
foxes were considered separately, this result did not change (P>0.063). 
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Discussion 
This study is the first report of seroprevalence to C. burnetii in bank voles, field voles, wood 
mice, foxes and cats in the UK. In other species of rodents, a seroprevalence of 9.7% (3/31) 
has been reported in wild rats and 3.2 % (1/31) in wild mice in Northern Ireland (McCaughey 
et al. 2010) but in the rest of the UK this pathogen has only been reported in wild brown rats 
in England (Webster, Lloyd, & Macdonald 1995). Seropositive cats and wild carnivores have 
been reported before, including foxes in the US (McQuiston and Childs 2002), but not in the 
UK.  
In this study, all species investigated were seropositive in all seasons, with seroprevalence 
varying from 1.8-72.7% depending on species and study area. The year round detection of 
seropositive rodents and foxes in all study areas indicates that these species could maintain 
C. burnetii as reservoir hosts, as indicated for brown rats in previous studies (Reusken 2011; 
Webster, Lloyd, & Macdonald 1995). Seasonal and area differences in levels of 
seropositivity could be due to many possible factors, including the intrinsic differences in 
study areas selected in terms of habitat type, species population density, distribution and 
home range size, and presence and degree of direct or indirect contact with other possible 
sources of C. burnetii infection such as domestic livestock. In studies of other pathogens, 
such as hantavirus in wild rodents population density and seroprevalence have been shown to 
be highly dependent on habitat type (Heyman et al. 2009; Olsen 1975). Seroprevalence in 
rodents was highest (21.9%) in the Pentlands area with evidence of spatial clustering. This 
was the most agricultural of the study areas, and the cluster associated with the very high 
seroprevalence (>60%, Figure 3) was adjacent to farmland on which sheep were grazed and 
lambed. Although clinical disease due to C. burnetii had not been reported in sheep or cattle 
on this farm, and no routine testing for exposure was been carried out, it is possible that these 
rodents could have been exposed to higher levels of C. burnetii in this site from close contact 
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with ruminants or a contaminated environment, allowing “spillover” of C. burnetii to occur 
from livestock to wildlife (Reusken 2011). However, the finding that this high 
seroprevalence in wild rodents was not associated with disease incidence in livestock in this 
site could be due to many factors, such as insufficient levels of direct or indirect contact due 
to rodent or livestock density for infection by aerosol or ingestion, insufficient levels of 
viable extracellular pathogen, or that infected rodents were not excreting C. burnetii at times 
of year or in areas of pasture where livestock were being grazed in close proximity to enable 
a “spillback” effect to occur. The infection dynamics and route by which transmission of 
infection from wild rodents to livestock may occur is unclear, and greater understanding of 
this is necessary to determine the factors involved where a high prevalence in rodents might 
correspond to a higher risk of disease in livestock. For example, in addition to the possibility 
of vertical transmission or shedding during parturition, it is thought that arthropod vectors 
such as ticks may play a significant role in the transmission of C. burnetii among wild 
rodents and lagomorphs (Babudieri 1959, Marrie 1986), so more complex routes of 
transmission may be involved in maintenance of infection in rodent reservoirs and rodent to 
livestock transmission. 
It was interesting to note the overall increase in seroprevalence during the duration of the 
study (Figure 2), which was present in all three rodent species and in 2 of the 3 study areas. 
A direct explanation for this is not apparent, but could be related to cyclical fluctuations in 
rodent population density (Lambin et al. 2000). However, the concurrent decline in 
seroprevalence in domestic cats means the factors behind these change remain to be 
elucidated. 
The finding that seroprevalence was significantly higher in predator species than in prey in 
all study areas also provides some evidence that predator species (foxes and cats) could act as 
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indicators for the presence of C. burnetii in rodents, presumably by ingestion of these prey 
species, however the lack of correlation between seroprevalence levels in predator and prey 
species indicates that infection dynamics in these multi-host systems are likely to be complex 
and a single seroprevalence value in predator or prey species may be difficult to interpret in 
terms of assessing the degree of livestock or human disease risk. Exposure of predators to 
infected prey could also be occurring by other routes in addition to ingestion, such as via 
aerosols of parturient secretions (e.g. by exploration of rodent nesting areas), or via arthropod 
vectors; there may also be intraspecies maintenance of infection, and direct or indirect 
transmission from other wildlife species or livestock. 
A common approach for determining thresholds for ELISA tests is to analyse the optical 
densities of serum from known positive and negative populations, then placing the cut-off at 
an S/P between these two populations where overlap is minimised (Gardner et al. 
1996;Greiner et al. 1994). This is the approach adopted by the manufacturers of the current 
test for testing for Q fever in domestic ruminants (A. Lecoq, IDVet Ltd., pers. comm.). An 
alternative approach is to use the mean value from a known negative reference population 
and add a two-or three-fold standard deviation to the mean to this value to determine the 
threshold (Richardson et al. 1983). However, serological testing and interpretation of results 
in wildlife species is challenging because the majority of serologic tests designed for human 
or livestock pathogens, such as the one used in this study, have not been validated for use in 
non-target species (Greiner and Gardner 2000) and tend just to be directly transposed from 
use in domestic livestock species (Gardner, Hietala, & Boyce 1996).  
ELISA tests have been used in wildlife species previously, including black bears, various 
deer species, hares, monkeys, wild rats, raccoon dogs, serow, wild pigs and palm civets in 
Japan, where species-specific conjugated antibodies were also not available and were 
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replaced with conjugated Protein A and G (Ejercito et al. 1993). Ejercito et al. (1993) used a 
distribution analysis approach to determine threshold values of an ELISA test for a 
serosurvey of a variety of species of wild animals for antibodies against C. burnetii in Japan 
using a qualitative (titre) rather than quantitative (S/P) approach to the interpretation of 
results in the absence of known species specific thresholds. In their study, Ejercito et al 
determined a threshold value for considering a species positive by titrating serial dilutions 
(1:100 to 1:3,200) of serum for each animal and looking at the bimodal distribution of 
antibody titre per species. They report that, usually, two peaks of antibody titre distribution 
were observed in every species with a peak in the lower dilution and a peak in the higher one, 
and considered the tapering end of the first peak, which was the start of the second peak, to 
be the cut-off for seropositive samples. Species with only one peak at the low dilution were 
considered Coxiella-antibody negative. They found that species with a high antibody 
prevalence, such as black bears, deer and hares, usually had a 1:100 cut-off titre, whereas 
those with a low antibody prevalence such as monkeys and nutria (a rodent species) had a 
cut-off titre of 1:400. In another study, Webster and Macdonald (1995) used a direct IgG 
ELISA to test wild brown rats for antibodies to C. burnetii in addition to IFA testing and also 
used serial dilutions to determine a titre of >1:100 as positive (Webster and Macdonald 
1995).  
However, the lack of species-specific reference sera can make interpretation of test results in 
wildlife species difficult, particularly if there are very low proportions of suspected 
seropositive or seronegative animals and the two populations are not distinct. Furthermore, 
reports of ELISA test use cannot be found in species of rodents other than rats or nutria 
(Myocastor coypus), nor in foxes or domestic cats. This means that for many organisms and 
their hosts there is a requirement for a robust methodology that can be used to determine and 
interpret the seroprevalence in wild and/or novel species.  
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The methods employed within this paper attempt to address this issue, by employing a 
mixed-model analysis to separate the observed data into separate distributions assumed to 
represent negative and positive individuals, and selecting a new test threshold for the target 
species based on the fitted distributions. This approach has been used by others (e.g. to 
determine seroprevalence of Toxoplasma. gondii in sheep (Opsteegh 2010)), is statistically 
more rigorous than simply drawing a line on observed data ‘by eye’, and also provides a 
degree of precaution against misidentification of separate distributions by providing no prior 
information about the separation in means or relative variances of these two distributions.  
Although this methodology does assume that infected and uninfected animals would be 
represented by 2 distributions of ELISA values, as opposed to a more uniform continuous 
distribution, we would advocate this approach for any future studies involving a diagnostic 
test that has not been validated in the target species. While we adopted the standard approach 
to determining our thresholds via optimisation of the total sensitivity and specificity of the 
test, the approach could easily be modified to select a threshold based on a more specific 
optimisation criterion – for example, the highest test sensitivity with a specificity of 99%, or 
any other combination of characteristics. However, even with the approach we adopted very 
high specificities were obtained (>97%) indicating that our seroprevalence estimates are 
likely to be conservative, and therefore if anything an underestimation of true seroprevalence. 
In the present study, as in the studies by Ejercito et al. (1993) and Webster and Macdonald 
(1995) described above, the threshold value for being considered positive also varied 
between species - 10.3% for the three rodent species and 16.3% for cats and foxes. 
Sensitivity and specificity found in the present study were 93.5% and 99.2% respectively for 
prey, and 89.0% and 97.9% respectively for predators. In human studies, the ELISA also has 
a high sensitivity and good specificity. For example in the diagnosis of acute Q fever in man, 
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the ELISA has a reported sensitivity of 80% for anti-phase II IgG and 84% for anti-phase II 
IgM and a specificity of >99% in one study (Waag et al. 1995), and in a other study a 
specificity of 97.7% and sensitivity of 95.65% for anti-phase II IgM (Frangoulidis et al. 
2006).  
One way of increasing confidence in the results found and interpretation of thresholds would 
have been to compare the results of the ELISA test used in this study with results using 
another serological test method such as CF or IFA. However, due to intrinsic differences 
between tests, interpretation can be difficult – for example the positive control in the ELISA 
test used was likely to be negative by CF (A LeCoq, IDVet, personal communication), 
because complement fixing antibodies appear later after exposure to C. burnetii, although 
they persist for long periods after illness (Murphy and Field 1970). Due to the limited 
amounts of serum available from the species tested in this study, use of another test was not 
undertaken but would be highly desirable.  
Overall, this study confirms that wildlife species have the potential to contribute significantly 
to reservoirs of Q-fever infection for both livestock and humans, and wildlife surveillance 
may be a useful tool in monitoring patterns of infection and potential disease risk. The high 
seroprevalence in domestic cats also highlights the potential zoonotic risk of this species. 
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Table 1. Seroprevalence for C. burnetii (with exact binomial 95% confidence intervals) 
for rodents, cats and foxes in each study area, with number positive for C. burnetii as 
determined by threshold analysis  
Species 
 
 C. burnetii results 
 
 
Area Total Positive Seroprevalence (95% CI) 
Prey     
 Bank vole Pentlands 102 20 19.6 (12.4-28.7) 
  Borders 17 3 17.7 (3.8-43.4) 
  Cumbria 61 8 13.1 (5.8-24.2) 
 
 
Total 180 31 17.2 (12.0-23.6) 
 Field vole Pentlands 97 28 28.9 (20.1-39.0) 
  Borders 99 6 6.1 (2.3-12.7) 
  Cumbria 113 25 22.1 (14.9-30.9) 
 
 
Total 309 59 19.1 (14.9-23.9) 
 Wood mouse Pentlands 153 29 19.0 (13.1-26.1) 
  Borders 55 1 1.8 (0.1-9.7) 
  Cumbria 99 18 18.2 (11.8-27.2) 
 
 
Total 307 48 15.6 (11.8-20.2) 
 All Pentlands 352 77 21.9 (17.7-26.6) 
  Borders 171 10 5.9 (2.8-10.5) 
  Cumbria 273 51 18.7 (14.2-23.8) 
 
 
Total 796 138 17.3 (14.8-20.2) 
Predator 
 
   
 Cat Pentlands 6 2 33.3 (4.3-77.7) 
  Borders 11 8 72.7 (39.0-94.0) 
  Cumbria 9 6 66.7 (29.9-92.5) 
 
 
Total 26 16 61.5 (40.6-79.8) 
 Fox Pentlands 17 5 29.4 (10.3-56.0) 
  Borders 39 25 64.1 (47.2-78.8) 
  Cumbria 46 12 26.1 (14.3-41.1) 
 
 
Total 102 42 41.2 (31.5-51.4) 
 All 
 
128 58 45.3 (36.5-54.4) 
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Figure legends 
Figure 1. Distribution of S/P values for (a) prey and (b) predator species (light grey bars). 
Solid curves are the fitted distributions using median estimates of the mean and variance of 
the two distributions from the MCMC analysis, with the compound distribution derived from 
these constituent normal distributions added on top. The best estimate threshold associated 
with the optimised maximum sum for specificity and sensitivity is shown as a vertical solid 
line. 
Figure 2. Plot of the seroprevalence observed in prey species with sample month. Vertical 
lines indicate the exact binomial 95% confidence interval and the solid thick line the fitted 
line from the GLMEb statistical model. 
Figure 3. Summary map of the seroprevalences of the rodent and fox and cat samples for the 
3 study areas (Pentlands, Borders and Cumbria). The seroprevalence of samples positive at a 
sampling site indicated by the proportion of each pie chart darkly shaded. The large pie charts 
are for rodents and range from 1-82 rodents and for the predators 1-10 foxes and 1-5 cats. 
The smaller pie charts with semi-transparent circles underneath are fox pie charts with fox 
territories of approximately 10km2 also indicated. For the Borders area a sample was also 
obtained from one cat (positive) where the owner lived 8km north of the area in map (not 
shown), and for the Cumbria area 2 cat samples (1 positive, 1 negative) were also obtained 
where the owners lived either lived over 4km north of the area in map (not shown). 
 
Supplementary Figure 1. Plots of the seroprevalence observed in prey species with sample 
month subdivided by rodent species (a-c) or by study area (d-f). Vertical lines indicate the 
exact binomial 95% confidence interval and the solid thick line the fitted line from the 
GLMEb statistical model 



